Lack of agreement between cervicography and cytology and the effect of human papillomavirus infection and viral load

Journal of Lower Genital Tract Disease

Volumn 10, Issue 4, 2006, Pages 229-237

  Schlecht, Nicolas F ^a,b   Trevisan, Andrea ^c,d   Baggio, Maria Luiza ^c   Galan, Lenice ^c   Duarte Franco, Eliane ^b   Greenberg, Mitchell D ^e   Rohan, Thomas E ^a   Ferenczy, Alex ^f   Villa, Luisa L ^c   Franco, Eduardo L ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e Omnia Corporation   (United States)

^f MCGILL UNIVERSITY   (Canada)

Author keywords

Cervical neoplasia; Cervicography; Diagnostic tests; Human papillomavirus; Pap smear

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BRAZIL; CARCINOGENICITY; CERVICOGRAPHY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GENITAL SYSTEM EXAMINATION; HABIT; HEALTH CENTER; HUMAN; HUMAN CELL; HYGIENE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATERNAL WELFARE; MEDICAL EXAMINATION; MEDICAL PHOTOGRAPHY; MICROSCOPY; OLIGONUCLEOTIDE PROBE; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; REPRODUCTIVE HEALTH; RISK FACTOR; SCREENING TEST; SQUAMOUS EPITHELIUM; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; VIRUS INFECTION; VIRUS LOAD; WART VIRUS;

ADOLESCENT; ADULT; AGED; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; OBSERVER VARIATION; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; VAGINA; VAGINAL SMEARS; VIRAL LOAD;

EID: 33749448545     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.lgt.0000225892.03613.2c     Document Type: Article

References (30)

1. Miller AB, Nazeer S, Fonn S, Brandup-Lukanow A, Rehman R, Cronjé H, et al. Report on consensus conference on cervical cancer screening and management. Int J Cancer 2000;86:440-7.
2. Stafl A. Cervicography: A new method for cervical cancer detection. Am J Obstet Gynecol 1981;139:815-25.
3. Herrero R, Brinton LA, Reeves WC, Brenes MM, de Britton RC, Gaitan E, et al. Screening for cervical cancer in Latin America: A case-control study. Int J Epidemiol 1992;21:1050-6.
4. Barton SE, Jenkins D, Hollingworth A, Cuzick J, Singer A. An explanation for the problem of false-negative cervical smears. Br J Obstet Gynaecol 1989;96:482-5.
5. Mould TA, Singer A, Mansell ME, Gallivan S. Cervicography to triage women with borderline or mild dyskaryotic cervical Pap smears. Eur J Gynaecol Oncol 2000;21:264-6.
6. Costa S, Sideri M, Bucchi L, Schettino F, Maini I, Spinaci L, et al. Cervicography and HPV DNA testing as triage criteria for patients with abnormal pap smear. Gynecol Oncol 1998;71:404-9.
7. Ferreccio C, Bratti MC, Sherman ME, Herrero R, Wacholder S, Hildesheim A, et al. A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 2003;12:815-23.
8. Baldauf JJ, Dreyfus M, Lehmann M, Ritter J, Philippe E. Cervical cancer screening with cervicography and cytology. Eur J Obstet Gynecol Reprod Biol 1995;58:33-9.
9. Nuovo J, Melnikow J, Hutchison B, Paliescheskey M. Is cervicography a useful diagnostic test? A systematic overview of the literature. J Am Board Fam Pract 1997;10:390-7.
10. Ferris DG, Schiffman M, Litaker MS. Cervicography for triage of women with mildly abnormal cervical cytology results. Am J Obstet Gynecol 2001;185:939-43.
11. Schneider DL, Herrero R, Bratti C, Greenberg MD, Hildesheim A, Sherman ME, et al. Cervicography screening for cervical cancer among 8460 women in a high-risk population. Am J Obstet Gynecol 1999;180:290-8.
12. Cronjé HS, Cooreman BF, Beyer E, Bam RH, Middlecote BD, Divall PD. Screening for cervical neoplasia in a developing country utilizing cytology, cervicography and the acetic acid test. Int J Gynaecol Obstet 2001;72:151-7.
13. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, et al. Cervical cancer control, priorities and new directions. Int J Cancer 2004;108:329-33.
14. Franco E, Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Pan Am J Public Health 1999;6:223-33.
15. Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. J Natl Cancer Inst 2003;95:1336-43.
16. Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001;286:3106-14.
17. Herbst AL. The Bethesda system for cervical/vaginal cytologic diagnoses. Clin Obstet Gynecol 1992;35:22-7.
18. Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991;265:472-7.
19. Hildesheim A, Schiffman MH, Gravitt PE, Glass AG, Greer CE, Zhang T, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
20. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, et al. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J Infect Dis 1994;170:1077-85.
21. Caballero OL, Villa LL, Simpson AJ. Low stringency-PCR (LS-PCR) allows entirely internally standardized DNA quantitation. Nucleic Acids Res 1995;23:192-3.
22. Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003;103:519-24.
23. van den Brule AJ, Snijders PJ, Gordijn RL, Bleker OP, Meijer CJ, Walboomers JM. General primer-mediated polymerase chain reaction permits the detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer 1990;45:644-9.
24. Schneider A, Zahm DM. New adjunctive methods for cervical cancer screening. Obstet Gynecol Clin North Am 1996;23:657-73.
25. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.
26. Durst M, Glitz D, Schneider A, zur Hausen H. Human papillomavirus type 16 (HPV 16) gene expression and DNA replication in cervical neoplasia: analysis by in situ hybridization. Virology 1992;189:132-40.
27. Longworth MS, Laimins LA. Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 2004;68:362-72.
28. Denny L, Kuhn L, Pollack A, Wainwright H, Wright TC Jr. Evaluation of alternative methods of cervical cancer screening for resource-poor settings. Cancer 2000;89:826-33.
29. Cronjé HS, van Rensburg E, Niemand I, Cooreman BF, Beyer E, Divall P. Screening for cervical neoplasia during pregnancy. Int J Gynaecol Obstet 2000;68:19-23.
30. Coibion M, Autier P, Vandam P, Delobelle A, Huet F, Hertens D, et al. Is there a role for cervicography in the detection of premalignant lesions of the cervix uteri? Br J Cancer 1994;70:125-8.